Premium
Pathological factors associated with survival benefit from adjuvant chemotherapy ( ACT ): a population‐based study of bladder cancer
Author(s) -
Booth Christopher M.,
Siemens D. Robert,
Wei Xuejiao,
Peng Yingwei,
Berman David M.,
Mackillop William J.
Publication year - 2015
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12913
Subject(s) - lymphovascular invasion , medicine , hazard ratio , cystectomy , bladder cancer , population , proportional hazards model , confidence interval , stage (stratigraphy) , oncology , cancer , cancer registry , urology , metastasis , paleontology , environmental health , biology
Objective To evaluate whether pathological factors are associated with differential effect of adjuvant chemotherapy ( ACT ). Patients and Methods In this population‐based retrospective cohort study, we linked electronic records of treatment and surgical pathology to the O ntario Cancer Registry. The study population included all patients with muscle‐invasive bladder cancer undergoing cystectomy in O ntario 1994–2008. Factors associated with overall ( OS ) and cancer‐specific survival ( CSS ) were evaluated using C ox proportional hazards. We tested for interaction between the following variables and ACT effect‐size: N ‐stage, margin status, T ‐stage, and lymphovascular invasion ( LVI ). Results The study population included 2802 patients; 19% were treated with ACT . Interaction terms with ACT for OS / CSS are: N ‐stage (both P < 0.001); margin status ( P = 0.054/ P = 0.048); T‐stage ( P = 0.509/ P = 0.286); and LVI ( P = 0.361/ P = 0.405). Magnitude of effect for ACT was greater for patients with node‐positive disease [ OS : hazard ratio ( HR ) 0.56, 95% confidence interval ( CI ) 0.47–0.67; CSS : HR 0.60, 95% CI 0.49–0.72] than for patients with node‐negative disease ( OS : HR 0.80, 95% CI 0.61–1.03; CSS : HR 0.79, 95% CI 0.59–1.07). ACT was also associated with greater effect among patients with involved margins ( OS : HR 0.45, 95% CI 0.33–0.62; CSS : HR 0.40, 95% CI 0.28–0.57) compared with patients with negative margins ( OS : HR 0.75, 95% CI 0.65–0.87; CSS : HR 0.79, 95% CI 0.67–0.93). Conclusions In this population‐based cohort study we observe evidence of interaction between ACT effect and nodal stage and surgical margin status. Our results suggest that patients at highest risk of disease recurrence may derive greatest benefit from ACT .